Hepatic Oxalate Overproduction As A Driver And Therapeutic Target In NASH And Atherosclerosis

被引:0
|
作者
Das, Sandeep
Finney, Alexandra C.
Kumar, Dhananjay
Liu, Yuhao
Rohilla, Sumati
Anand, Sumit Kumar
Nunez, Kelly
Liu, Zhipeng
Pearson-Gallion, Brenna
Abdullah, Chowdhury S.
Cockerham, Elizabeth D.
Bhuiyan, Md Shenuarin
Orr, Wayne W.
Garcia-Barrio, Minerva T.
Zhang, Jifeng
Liu, Wanqing
Chen, Y. Eugene
Thevenot, Paul
Cohen, Ari
Yurdagul, Arif
Rom, Oren
机构
关键词
Atherosclerosis; Mitochondria; Metabolism;
D O I
10.1161/atvb.43.suppl_1.684
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 684
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Dysregulated oxalate metabolism is a driver and therapeutic target in atherosclerosis
    Liu, Yuhao
    Zhao, Ying
    Shukha, Yousef
    Lu, Haocheng
    Wang, Lu
    Liu, Zhipeng
    Liu, Cai
    Zhao, Yang
    Wang, Huilun
    Zhao, Guizhen
    Liang, Wenying
    Fan, Yanbo
    Chang, Lin
    Yurdagul, Arif, Jr.
    Pattillo, Christopher B.
    Orr, A. Wayne
    Aviram, Michael
    Wen, Bo
    Garcia-Barrio, Minerva T.
    Zhang, Jifeng
    Liu, Wanqing
    Sun, Duxin
    Hayek, Tony
    Chen, Y. Eugene
    Rom, Oren
    CELL REPORTS, 2021, 36 (04):
  • [2] Another therapeutic target for atherosclerosis
    Diker, Erdem
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2015, 43 (04): : 415 - 415
  • [3] Inflammation as a Therapeutic Target in Atherosclerosis
    Nguyen, Mau T.
    Fernando, Sanuja
    Schwarz, Nisha
    Tan, Joanne T. M.
    Bursill, Christina A.
    Psaltis, Peter J.
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (08)
  • [4] Inhibition of hepatic oxalate overproduction ameliorates metabolic dysfunction-associated steatohepatitis
    Das, Sandeep
    Finney, Alexandra C.
    Anand, Sumit Kumar
    Rohilla, Sumati
    Liu, Yuhao
    Pandey, Nilesh
    Ghrayeb, Alia
    Kumar, Dhananjay
    Nunez, Kelley
    Liu, Zhipeng
    Arias, Fabio
    Zhao, Ying
    Pearson-Gallion, Brenna H.
    McKinney, M. Peyton
    Richard, Koral S. E.
    Gomez-Vidal, Jose A.
    Abdullah, Chowdhury S.
    Cockerham, Elizabeth D.
    Eniafe, Joseph
    Yurochko, Andrew D.
    Magdy, Tarek
    Pattillo, Christopher B.
    Kevil, Christopher G.
    Razani, Babak
    Bhuiyan, Md. Shenuarin
    Seeley, Erin H.
    Galliano, Gretchen E.
    Wei, Bo
    Tan, Lin
    Mahmud, Iqbal
    Surakka, Ida
    Garcia-Barrio, Minerva T.
    Lorenzi, Philip L.
    Gottlieb, Eyal
    Salido, Eduardo
    Zhang, Jifeng
    Orr, A. Wayne
    Liu, Wanqing
    Diaz-Gavilan, Monica
    Chen, Y. Eugene
    Dhanesha, Nirav
    Thevenot, Paul T.
    Cohen, Ari J.
    Yurdagul Jr, Arif
    Rom, Oren
    NATURE METABOLISM, 2024, 6 (10) : 1939 - 1962
  • [5] Fatty Acid Esterification as a NASH Therapeutic Target
    Sakuma, Ikki
    Vatner, Daniel F.
    CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2024, 17 (02): : 311 - 312
  • [6] The monocyte/macrophage as a therapeutic target in atherosclerosis
    Saha, Prakash
    Modarai, Bijan
    Humphries, Julia
    Mattock, Katherine
    Waltham, Matthew
    Burnand, Kevin G.
    Smith, Alberto
    CURRENT OPINION IN PHARMACOLOGY, 2009, 9 (02) : 109 - 118
  • [7] Macrophage: A Key Therapeutic Target in Atherosclerosis?
    Taghizadeh, Eskandar
    Taheri, Forough
    Renani, Pedram G.
    Reiner, Zeljko
    Navashenaq, Jamshid G.
    Sahebkar, Amirhossein
    CURRENT PHARMACEUTICAL DESIGN, 2019, 25 (29) : 3165 - 3174
  • [8] Autophagy: An Exposing Therapeutic Target in Atherosclerosis
    Luo, Yun
    Lu, Shan
    Zhou, Ping
    Ai, Qi-Di
    Sun, Gui-Bo
    Sun, Xiao-Bo
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2016, 67 (03) : 266 - 274
  • [9] Cyclophilins in Atherosclerosis: A New Therapeutic Target?
    Bukrinsky, Michael
    Orekhov, Alexander
    Ditiatkovski, Michael
    Sviridov, Dmitri
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (33) : 5904 - 5908
  • [10] NAMPT: A critical driver and therapeutic target for cancer
    Gasparrini, Massimiliano
    Audrito, Valentina
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2022, 145